A detailed history of Toroso Investments, LLC transactions in Organon & Co. stock. As of the latest transaction made, Toroso Investments, LLC holds 76,525 shares of OGN stock, worth $1.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
76,525
Previous 69,195 10.59%
Holding current value
$1.17 Million
Previous $1.43 Million 2.16%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $136,704 - $168,809
7,330 Added 10.59%
76,525 $1.46 Million
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $996,691 - $1.25 Million
-57,117 Reduced 45.22%
69,195 $1.43 Million
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $895,217 - $1.22 Million
64,965 Added 105.9%
126,312 $2.37 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $432,218 - $683,655
39,472 Added 180.44%
61,347 $884,000
Q3 2023

Nov 15, 2023

SELL
$16.59 - $23.77 $60,155 - $86,190
-3,626 Reduced 14.22%
21,875 $379,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $21,967 - $28,078
-1,140 Reduced 4.28%
25,501 $531,000
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $299,987 - $449,280
14,005 Added 110.83%
26,641 $627,000
Q4 2022

Feb 15, 2023

BUY
$23.31 - $28.61 $294,545 - $361,515
12,636 New
12,636 $353,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $49,231 - $60,489
-1,555 Reduced 11.92%
11,487 $388,000
Q1 2022

May 20, 2022

BUY
$30.45 - $39.36 $397,128 - $513,333
13,042 New
13,042 $456,000
Q4 2021

Feb 16, 2022

SELL
$28.67 - $37.13 $359,493 - $465,573
-12,539 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $358,991 - $446,889
12,539 New
12,539 $411,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.